Total planned funding: $476,038,904
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $129,444,387 |
Zambia | $91,236,851 |
Mozambique | $73,486,017 |
South Africa | $25,883,323 |
Vietnam | $21,638,015 |
Kenya | $13,502,332 |
India | $12,687,057 |
Haiti | $10,464,552 |
Ghana | $9,732,500 |
Tanzania | $9,060,431 |
Burundi | $8,881,411 |
Côte d'Ivoire | $8,355,736 |
Botswana | $7,230,003 |
Indonesia | $7,201,794 |
Papua New Guinea | $5,486,330 |
South Sudan | $5,135,929 |
Democratic Republic of the Congo | $4,392,175 |
Zimbabwe | $4,344,201 |
Rwanda | $4,281,830 |
Asia Regional Program | $3,400,093 |
Eswatini | $3,187,187 |
Malawi | $3,013,446 |
Namibia | $2,707,568 |
Caribbean Region | $2,525,420 |
Angola | $2,466,719 |
Ethiopia | $2,222,911 |
Cambodia | $2,025,000 |
Uganda | $1,795,686 |
Dominican Republic | $250,000 |
Central Asia Region | $0 |
Organizational Types
NGO | $476,038,904 |
Program Areas
Care | $137,078,511 |
Treatment | $126,675,029 |
Prevention | $126,266,086 |
Governance and Systems | $48,158,531 |
Testing | $37,860,747 |
Budget Codes
HTXS: Treatment: Adult Treatment | $107,557,951 |
HVOP: Sexual Prevention: Other Sexual Prevention | $59,412,285 |
HKID: Care: Orphans and Vulnerable Children | $57,918,494 |
HBHC: Care: Adult Care and Support | $54,656,587 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $48,046,704 |
HVCT: Testing: HIV Testing and Counseling | $37,860,747 |
PDTX: Treatment: Pediatric Treatment | $19,117,078 |
HLAB: Laboratory Infrastructure | $17,588,745 |
OHSS: Health Systems Strengthening | $16,367,432 |
HVSI: Strategic Information | $14,202,354 |
HVTB: Care: TB/HIV | $12,802,340 |
PDCS: Care: Pediatric Care and Support | $11,701,090 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,082,638 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,561,830 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $4,271,886 |
HMIN: Biomedical Prevention: Injection Safety | $472,817 |
HMBL: Biomedical Prevention: Blood Safety | $417,926 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$476,038,904
View countries